CHANGES IN SERUM CONCENTRATIONS OF GROWTH-HORMONE, INSULIN, INSULIN-LIKE-GROWTH-FACTOR AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 ANDPROTEIN-3 AND URINARY GROWTH-HORMONE EXCRETION DURING THE MENSTRUAL-CYCLE
A. Juul et al., CHANGES IN SERUM CONCENTRATIONS OF GROWTH-HORMONE, INSULIN, INSULIN-LIKE-GROWTH-FACTOR AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 ANDPROTEIN-3 AND URINARY GROWTH-HORMONE EXCRETION DURING THE MENSTRUAL-CYCLE, Human reproduction, 12(10), 1997, pp. 2123-2128
Few studies exist on the physiological changes in the concentrations o
f growth hormone (GH), insulin-like growth factors (IGF) and ICE-bindi
ng proteins (IGFBP) within the menstrual cycle, and some controversy r
emains. We therefore decided to study the impact of endogenous sex ste
roids on the GH-IGF-IGFBP axis during the ovulatory menstrual cycle in
10 healthy women (aged 18-40 years). Blood sampling and urinary colle
ction was performed every morning at 0800 h for 32 consecutive days. E
very second day the subjects were fasted overnight before blood sampli
ng. Follicle stimulating hormone, luteinizing hormone (LH), oestradiol
, progesterone, IGF-I, 1GFBP-3, sex hormone-binding globulin, dihydroe
piandrosterone sulphate and GH were determined in all samples, whereas
insulin and IGFBP-1 were determined in fasted samples only. Serum IGF
-I concentrations showed some fluctuation during the menstrual cycle,
with significantly higher values in the luteal phase compared to the p
roliferative phase (P < 0.001). Mean individual variation in IGF-I con
centrations throughout the menstrual cycle was 13.2% (SD 4.3; range 0.
1-18.3%). There were no cyclic changes in IGFBP-3 serum concentrations
and no differences in 1GFBP-3 concentrations between the luteal and t
he proliferative phases. Mean individual variation in IGFBP-3 concentr
ations throughout the menstrual cycle was 8.8% (SD 2.7; range 3.2-14.1
). IGFBP-1 concentrations were inversely associated with insulin conce
ntrations, and showed a significant pre-ovulatory increase that return
ed to baseline at the day of the LH surge. Easting insulin concentrati
ons showed large fluctuations throughout the menstrual cycle without a
ny distinct cyclic pattern. No cyclic changes in urinary GH excretion
during menstrual cycle were detected. We conclude that, although ICE-I
concentrations are dependent on the phase of the menstrual cycle, the
variation in IGF-I concentrations throughout the menstrual cycle is r
elatively small. Therefore, the menstrual cycle does not need to be co
nsidered when evaluating IGF-I or 1GFBP-3 serum values in women suspec
ted to have GH deficiency.